These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Hooten KG; Beers DR; Zhao W; Appel SH Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201 [TBL] [Abstract][Full Text] [Related]
7. Evidence for an early innate immune response in the motor cortex of ALS. Jara JH; Genç B; Stanford MJ; Pytel P; Roos RP; Weintraub S; Mesulam MM; Bigio EH; Miller RJ; Özdinler PH J Neuroinflammation; 2017 Jun; 14(1):129. PubMed ID: 28651542 [TBL] [Abstract][Full Text] [Related]
8. A system mathematical model of a cell-cell communication network in amyotrophic lateral sclerosis. Shao H; He Y; Li KC; Zhou X Mol Biosyst; 2013 Mar; 9(3):398-406. PubMed ID: 23287963 [TBL] [Abstract][Full Text] [Related]
9. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629 [TBL] [Abstract][Full Text] [Related]
10. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013 [TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of the Major Histocompatibility Complex Class I in Amyotrophic Lateral Sclerosis. Chiarotto GB; Nardo G; Trolese MC; França MC; Bendotti C; Rodrigues de Oliveira AL Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104236 [TBL] [Abstract][Full Text] [Related]
17. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Appel SH; Beers DR; Henkel JS Trends Immunol; 2010 Jan; 31(1):7-17. PubMed ID: 19879804 [TBL] [Abstract][Full Text] [Related]